Phase II Trial With Metronomic, Capecitabine Plus Oral Vinorelbine for Metastatic Breast Cancer

NCT01941771 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

110

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Arm B Vinorelbine (Navelbine oral) Capecitabine (Xeloda)
DRUG: Arm A Vinorelbine (Navelbine oral) Capecitabine (Xeloda)

Sponsor

University of Aarhus

Collaborators

[object Object]